Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
50
# OF OVERLAPPING
HOLDINGS
IBB
249
HOLDINGS
24%
ALSO IN BBP
BBP
65
HOLDINGS
82%
ALSO IN IBB
SECTOR DRIFT (IBB minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
INSMED INC | 3.1% | 3.3% | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 5.4% | 3.0% | 3.0% |
|
GILEAD SCIENCES INC | 7.7% | 2.1% | 2.1% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% | 2.9% | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.7% | 1.8% | 1.7% |
IBB Overweight Relative to BBP
|
VERTEX PHARMACEUTICALS INC | 6.3% |
|
GILEAD SCIENCES INC | 5.6% |
|
AMGEN INC | 5.6% |
|
REGENERON PHARMACEUTICALS | 4.2% |
|
IQVIA HOLDINGS INC | 3.5% |
 |
ARGENX SE ADR | 3.3% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.4% |
|
NATERA INC | 2.4% |
|
WATERS CORP | 2.0% |
IBB Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |
|
RHYTHM PHARMACEUTICALS, INC. | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.3% |
 |
THERAVANCE BIOPHARMA INC | -2.3% |
|
LEXICON PHARMACEUTICALS, INC. | -2.2% |